newsfilter
← Latest News
ACCESS Newswire·

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / September 9, 2024 / CureVac N.V. , a global biopharmaceutical company developing a new class of transformative medicines based on